Eyeworld

Archives EyeWorld Daily News Supplements News resources EyeWorldTV.com EyeWorld.org ASCRS @EyeWorldMag eyeworldmagazine EyeWorld Magazine ASCRS•ASOA SYMPOSIUM & CONGRESS, SAN DIEGO 2015 digital.eyeworld.org EyeWorld Daily News • The official ASCRS•ASOA Show Daily P remium IOLs can offer advantages to all patients, including those with glau- coma, but patient selection is key, said Richard Lewis, MD, Sacramento, California, at ASCRS Glaucoma Day. Physicians must use modern IOL formulas and avoid multifocal IOLs in glaucoma patients with cupping or visual loss, he added. The decision regarding a pre- mium lens in patients with glauco- ma should include a review of the patient's visual needs, the role of glasses in his or her life, and glauco- ma status. Saturday, May 6, 2017 continued on page 5 Luther Fry, MD Dr. Lewis discusses premium IOLs for glaucoma patients at Glaucoma Day. Connection between glaucoma, cataract surgery a focus at Glaucoma Day Honored Guests bring their expertise to this year's ASCRS meeting L uther Fry, MD, Garden City, Kansas, and Y.C. Lee, MD, Perak, Malaysia, are Hon- ored Guests of ASCRS and the Asia-Pacific Association of Cataract & Refractive Surgeons (APACRS) at this year's meeting. At today's ASCRS Opening General Ses- sion, they will be honored for their contributions to ophthalmology. Dr. Fry is the founder of Fry Eye Associates in Garden City. He is a clinical assistant professor in the De- partment of Ophthalmology at the University of Kansas Medical Center. Previously named as one of the "Best Doctors in America," Dr. Fry specializes in cataract extraction and intraocular lens implantation. He has performed more than 32,000 cataract surgeries. He is board certified by the American Board of Ophthalmolo- gy. He is also certified in cataract surgery by the American Board of Eye Surgeons. He is a member of the board of directors for the Ophthal- mic Anesthesia Society and is a past president of the society. He is also a member of the board of directors for the American College of Eye Sur- geons and is its past president. Dr. Fry received his medical degree from the University of Kansas Medical School and completed Y.C. Lee, MD Dr. Lewis reminded attendees that IOL calculation formulas have advanced tremendously in the past 10 years, with the recent addition of effective lens position to the formula mix. The use of a current IOL calculation formula is crucial, he said. Dr. Lewis briefly addressed pros and cons of both multifocal and toric IOLs. Despite the advantages of toric IOLs, "I'm always surprised at how few glaucoma surgeons put them in," he said. As glaucoma patients are more likely to have pupil issues, surgeons should be ready to medically man- continued on page 5 age this problem or use devices like a Malyugin ring or capsular tension ring. Surgeons should also aim to minimize the risk glaucoma patients have for cystoid macular edema. Femtosecond laser-assisted cataract surgery generates a lot of clinical interest, and Leon Hern- don, MD, Durham, North Carolina, addressed whether it's a technology that glaucoma surgeons should use when they perform cataract surgery. He concluded that most glaucoma patients are candidates for it except for those with poorly controlled IOP, severe glaucoma, or poor dilation. Despite its advantages, it's not yet by Vanessa Caceres EyeWorld Contributing Writer Dr. Lindstrom delivers the second annual Steinert Lecture at Refractive Day. continued on page 3 by Liz Hillman EyeWorld Staff Writer T he second annual ASCRS Refractive Day addressed corneal and lens-based refractive surgery and featured the notable Steinert Lecture given by Richard Lindstrom, MD, Minneapolis. Though Roger Steinert, MD, died in June 2017 after battling glio- blastoma, David Chang, MD, Los Altos, California, said his spirit lives on in the annual ASCRS Refractive Day Steinert Lecture. "So much can happen in so little time and impermanence is a circumstance we all must endure," April Steinert, Dr. Steinert's wife, said, introducing the lecture. "Today it may appear that I stand up here alone, but I assure you that is not the case. Roger is here in this room with us," she continued. Mrs. Steinert went on to intro- duce Dr. Lindstrom, listing his many accomplishments and highlighting his longtime friendship with Dr. Steinert. In the lecture, Dr. Lindstrom shared his thoughts on the current state of laser refractive surgery. Though LASIK reached its high in the late 1990s and early 2000s, after 9/11 and then the Great Recession there was a decline in the elective procedure from which it has not yet recovered. digital.eyeworld.org Saturday, April 14, 2018 EyeWorld Daily News • The official ASCRS•ASOA Show Daily Steinert Lecture a highlight of second annual ASCRS Refractive Day Dr. Rhee came out on top in the Glaucoma Fighting Championship debate against Dr. Ahmed on the question "Is trabeculectomy dead?" by Liz Hillman EyeWorld Staff Writer Glaucoma Fighting Championship rematch: 'Is trabeculectomy dead?' Doug Rhee, MD, argues trab is alive, remains reigning GFC champ D ouglas Rhee, MD, Cleveland, remains the undefeated champ of the Glaucoma Fighting Championship (GFC) in a rematch debate against Iqbal "Ike" Ahmed, MD, Toronto, Canada, over whether trabeculectomy is dead. The challengers of the Glauco- ma Day event, refereed by Steven Sarkisian, MD, Oklahoma City, pulled no punches, at least not lit- erally, but didn't hold back on their snarky jibes toward each other or their own pithy arguments in favor of their position. Dr. Rhee, starting off in the blue corner, argued that trabeculectomy is not dead and Dr. Ahmed in the red corner gave his thoughts to the contrary. Dr. Ahmed, as the challenger, started off the debate. Microinvasive glaucoma surgery (MIGS), subcon- junctival microstents and better continued on page 6 ASCRS DAILY NEWS S A T U R D AY, M AY 4 , 2 019 | A S C R S A S O A A N N U A L M E E T I N G by Liz Hillman EyeWorld Senior Staff Writer T he 2019 Steinert Refrac- tive Lecture at the 2019 ASCRS Refractive Day was presented by Eric Donnenfeld, MD, Rock- ville Centre, New York. Dr. Donnenfeld has published hundreds of peer-re- viewed papers, participated in more than 60 FDA clinical trials, by Liz Hillman EyeWorld Senior Staff Writer S everal presentations during the 2019 ASCRS Refractive Day covered technologies and innova- tions that could enhance premium refractive lens surgery. An automated capsulotomy device has the ability to create a precise, reproducible capsulor- hexis, but Kevin Waltz, MD, Moving premium refractive lens surgery forward Steinert Refractive Lecture seeks to correct LASIK myths and misconceptions Ocular 1 BVI 1 WHEN RELIABILITY COUNTS THE RIGHT PACK MATTERS bvimedical.com Minimize your pack-building time Expedite your OR experience CustomEyes ® your pack BVI, BVI Logo and all other trademarks (unless noted otherwise) are property of Beaver-Visitec International, Inc. ("BVI") © 2019 BVI. 1498237-03 Visit BVI BOOTH 1206 Dextenza ® BIG TIME'I � ION VISIT BOOTH #1737 1 Sawhney AS, �arrett Bassett M, Blizzard C, inventors; Incept, LLC, assignee Drug delivery through hydrogel plugs. US patent 8,409,606 82. April 2, 2013. © 2019 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. I PP-US-DX-0097 FOR FULL PRESCRIBING INFORMATION VISIT DEXTENZA.COM Indianapolis, said there might be secondary, long-term benefits of such technology as well. Dr. Waltz focused his talk on Zepto (Mynosys) because it is the only device FDA-approved in the U.S., but there are other automated capsulotomy devices. Studies have shown a Zep- to-created capsulotomy has a stronger, more tear-resistant edge when compared to femtosecond laser-created and manual capsulo- tomies. Zepto has also been asso- ciated with a reduced PCO rate, which Dr. Waltz said was "totally continued on page 4 continued on page 3 Dr. Holland presents Dr. Donnenfeld (left) with the Steinert Refractive Lecture award. unexpected" and could be due to "markedly reduced fibrosis inside the capsule." Five-year data, Dr. Waltz said, suggests that with less intracapsular fibrosis you could have less phimosis long-term. With these, Dr. Waltz said there "might be some hidden ben- efits to automated capsulotomies." Nuclear disassembly with miLOOP (Carl Zeiss Meditec) can have refractive benefits, said Sean Ianchulev, MD, New York. Dr. Ianchulev described research that suggests the cen- tripetal fragmentation that avoids stretching the capsular bag (unlike traditional centrifugal phaco-chop techniques) impacts effective lens position. This benefit is in addi- tion to the reduced phaco energy delivered to the eye for nuclear disassembly. In terms of innovation of premium lenses, Robert Maloney, MD, Los Angeles, highlighted the Light Adjustable Lens (RxSight). This lens is implanted in basic cataract surgery with no LRIs, no corneal marking, no intraop- erative aberrometry, and no axis

• Cover